| Watchers | 4,578 |
| 52-Wk Low | $1.50 |
| 52-Wk High | $5.39 |
| Market Cap | $3.26B |
| Volume | 1.78M |
| 52-Wk High | $5.39 |
| 52-Wk Low | $1.50 |
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Summit Therapeutics Inc market cap is $3.26B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Summit Therapeutics Inc 52 week high is $5.39 as of May 13, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Summit Therapeutics Inc 52 week low is $1.50 as of May 13, 2024.
Summit Therapeutics Inc stock price today is $4.65.
Summit Therapeutics Inc stock price yesterday was $4.78.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Summit Therapeutics Inc’s P/E ratio is -28.06.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Summit Therapeutics Inc P/B ratio is 73.8330.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Summit Therapeutics Inc's EBITDA is -25.11.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Summit Therapeutics Inc 50-day moving average is $4.08.
Summit Therapeutics Inc has 105 employees.